Clinical Trial Update: Eletriptan vs Sumatriptan: A Double-blind, Placebo-controlled, Multiple Migraine Attack Study [Phase 3]

View source ↗

Summary

Phase 3 trial comparing eletriptan to sumatriptan and placebo in adults with migraine with or without aura has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine with or Without Aura

Drugs mentioned

• Eletriptan (eletriptan)
• Sumatriptan (Sumatriptan)

Snippet

Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | Conditions: Migraine With or Without Aura | Phase 3 | Status: COMPLETED